A diagnostic assay for TERT promoter mutation detection in various cancer types including glioblastoma and melanoma.
Manufactured by
Daejeon, South Korea
PANAGENE will always make its best efforts to develop innovative platform technologies and strive to be a global leader in the field of molecular diagnostics. We, PANAGENE Inc. have been developing and launching accurate and convenient in vitro diagnostic products consistently from Oncology to Infectious Diseases. We exercise strict quality management policy and make efforts to meet global standards and appropriate regulations for our IVD products. PANAGENE has expertise especially in cancer-related molecular diagnostics including companion diagnostics using tissue or liquid biopsy. Our advanced technology provides not only high level of detection but also simple and convenient procedure to be used easily in the front-line hospitals and clinical laboratories. (EGFR, KRAS, NRAS, BRAF, PIK3CA, IDH1, IDH2, JAK2, BCR-ABL, c-KIT, TERT, EML4-ALK, ROS1) Also we apply our platform technology to maximize multiplex capability to detect using melting curve analysis with high-level performance. (HPV, STD, CRE, TB/NTM) Lastly, we have our automation extraction system to use with molecular diagnostics kits to provide full package solution for the user. The extraction machine is 100% in house developed and optimized with our kits. During this Pandemic, we are providing the machines and extraction kits to reach out who needs the testings. (Viral, FFPE, cfDNA extraction kits) PANAGENE is pursuing open innovation and seeking opportunity for collaboration with various organizations including pharmaceutical and diagnostics companies. We always welcome organizations who are interest in our technologies and/or products. We will do our best for customer satisfaction and for realizing our vision, “Platform Technology Provider”.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GENETRON HEALTH (BEIJING) CO., LTD
China · 3 relevant products
Shanghai Chemtron Biotech Co.,Ltd.
China · 1 relevant product
Hangzhou Biotest Biotech Co., Ltd
China · 1 relevant product
POCBio (Nexlab Co., Ltd.)
China · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
Lansion Biotechnology Co., Ltd.
China · 1 relevant product
AEHEALTH Limited
China · 1 relevant product
BioTeke Corporation(wuxi) Co.,Ltd
China · 1 relevant product
PreceDo Pharmaceuticals Co.Ltd.
China · 1 relevant product
Delta Care For Medical Industries
Egypt · 1 relevant product
58 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →3 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 110 closest product alternatives
GENETRON HEALTH (BEIJING) CO., LTD · China
A diagnostic kit for detecting TERT C228T and C250T promoter mutations in glioma patient tissue samples. It provides high sensitivity detecting mutations as low as 1% in 10ng/μL samples with specificity exceeding 99%. The kit delivers clear data output and objective interpretation without requiring subjective judgment. It supports convenient operation with capacity to test 90 samples in a single run within 1 hour using a compact system design minimizing contamination.
Shanghai Chemtron Biotech Co.,Ltd. · China
A diagnostic test for detecting tumor markers associated with various cancers. This test is used in oncology screening and monitoring.
Hangzhou Biotest Biotech Co., Ltd · China
A diagnostic test for detecting tumor markers in patient samples. This test is used in oncology screening and monitoring.
POCBio (Nexlab Co., Ltd.) · China
A diagnostic test for detecting tumor markers. This product is used in oncology screening and monitoring applications.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test providing precise tumor subtyping for improved treatment stratification. Supports personalized oncology management and therapeutic decision-making.
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic reagent for oncology marker detection. Enables rapid assessment of cancer-related biomarkers.
AEHEALTH Limited · China
In vitro diagnostic reagent for detection and measurement of tumor markers in patient specimens. Supports oncology screening and monitoring applications.
BioTeke Corporation(wuxi) Co.,Ltd · China
Immunoassay-based test for rapid detection of tumor-associated markers in clinical samples. Supports oncology screening and cancer diagnostics in clinical laboratories.
PreceDo Pharmaceuticals Co.Ltd. · China
Genetic screening for hereditary cancer susceptibility genes including BRCA and other tumor suppressors. This test enables early identification of high-risk individuals for surveillance.
Delta Care For Medical Industries · Egypt
A rapid diagnostic test for the detection of tumor markers. Used for screening and monitoring cancer-related biomarkers in clinical settings.
GMA Group Trading · Egypt
Molecular test for detection of epidermal growth factor receptor mutations in lung cancer diagnosis.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
98 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products